Motolimod
Title | Journal |
---|---|
A phase I dose-finding study of the novel Toll-like receptor 8 agonist VTX-2337 in adult subjects with advanced solid tumors or lymphoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20140715 |
VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. | Clinical cancer research : an official journal of the American Association for Cancer Research 20120115 |